Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: Development of a therapy against metastatic bladder cancer using an interleukin-2 surface-modified MB49 bladder cancer stem cells vaccine

Fig. 3

Animal experiment with the SA-IL-2 MCSCs vaccine. a In the protective experiment, experimental group mice exhibited a trend towards the smallest tumor volume. b In the protective experiment, mice in the experimental group had a longest survival. c In the therapeutic experiment, experimental group mice showed a trend towards the smallest tumor volume. d In the therapeutic experiment, experimental group mice had the longest survival. e In the specific experiment, experimental group mice showed a trend towards smaller tumor volume. f In the memory experiment, experimental mice group had a longer survival, SA-IL-2 streptavidin mouse interleukin-2, MCSCs MB49 bladder cancer stem cells, PBS phosphate-buffered saline

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512